Header Logo

Lisa Michelle Landrum

InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentObstetrics and Gynecology
AddressAAT 2400
800 Stanton L Young Blvd
Oklahoma City OK 73104
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Castellano T, John Maxwell IV, Adam Walter J, Thompson S, McMeekin DS, Landrum LM. Phase II trial of vaginal cuff brachytherapy followed by dose-dense chemotherapy in early stage endometrial cancer patients with enriched, high-intermediate risk factors for recurrence. Gynecol Oncol. 2021 Mar; 160(3):669-673. PMID: 33358492.
      Citations:    Fields:    
    2. Chen CCG, Lockrow EG, DeStephano CC, Nihira MA, Matthews C, Kammire L, Landrum LM, Anderson BD, Miyazaki D. Establishing Validity for a Vaginal Hysterectomy Simulation Model for Surgical Skills Assessment. Obstet Gynecol. 2020 11; 136(5):942-949. PMID: 33030877.
      Citations:    Fields:    Translation:Humans
    3. Tewari KS, Sill MW, Monk BJ, Penson RT, Moore DH, Lankes HA, Ramondetta LM, Landrum LM, Randall LM, Oaknin A, Leitao MM, Eisenhauer EL, DiSilvestro P, Van Le L, Pearl ML, Burke JJ, Salani R, Richardson DL, Michael HE, Kindelberger DW, Birrer MJ. Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062). Mol Cancer Ther. 2020 Aug 26. PMID: 32847980.
      Citations: 1     Fields:    
    4. Huh WK, Brady WE, Fracasso PM, Dizon DS, Powell MA, Monk BJ, Leath CA, Landrum LM, Tanner EJ, Crane EK, Ueda S, McHale MT, Aghajanian C. Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study. Gynecol Oncol. 2020 09; 158(3):562-569. PMID: 32641240.
      Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
    5. Shalowitz DI, Lefkowits C, Landrum LM, von Gruenigen VE, Spillman MA. Principles of ethics and critical communication during the COVID-19 pandemic. Gynecol Oncol. 2020 09; 158(3):526-530. PMID: 32622474.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    6. Chase D, Huang HQ, Monk BJ, Ramondetta LM, Penson RT, Gil K, Landrum LM, Leitao M, Oaknin A, Huh WK, Pulaski HL, Robison K, Guntupalli SR, Richardson D, Salani R, Sill MW, Wenzel LB, Tewari KS. Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study. Int J Gynecol Cancer. 2020 05; 30(5):596-601. PMID: 32114513.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    7. Castellano T, Ding K, Moore KN, Landrum LM. Simple Hysterectomy for Cervical Cancer: Risk Factors for Failed Screening and Deviation From Screening Guidelines. J Low Genit Tract Dis. 2019 Apr; 23(2):124-128. PMID: 30817687.
      Citations:    Fields:    Translation:Humans
    8. Richardson DL, Sill MW, Coleman RL, Sood AK, Pearl ML, Kehoe SM, Carney ME, Hanjani P, Van Le L, Zhou XC, Alvarez Secord A, Gray HJ, Landrum LM, Lankes HA, Hu W, Aghajanian C. Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial. JAMA Oncol. 2018 Feb 01; 4(2):196-202. PMID: 29242937.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    9. Cosgrove CM, Tritchler DL, Cohn DE, Mutch DG, Rush CM, Lankes HA, Creasman WT, Miller DS, Ramirez NC, Geller MA, Powell MA, Backes FJ, Landrum LM, Timmers C, Suarez AA, Zaino RJ, Pearl ML, DiSilvestro PA, Lele SB, Goodfellow PJ. An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. Gynecol Oncol. 2018 01; 148(1):174-180. PMID: 29132872.
      Citations: 10     Fields:    Translation:HumansCells
    10. Tewari KS, Sill MW, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, DiSaia PJ, Copeland LJ, Creasman WT, Stehman FB, Brady MF, Burger RA, Thigpen JT, Birrer MJ, Waggoner SE, Moore DH, Look KY, Koh WJ, Monk BJ. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017 Oct 07; 390(10103):1654-1663. PMID: 28756902.
      Citations: 67     Fields:    Translation:HumansCTClinical Trials
    11. von Gruenigen VE, Huang HQ, Beumer JH, Lankes HA, Tew W, Herzog T, Hurria A, Mannel RS, Rizack T, Landrum LM, Rose PG, Salani R, Bradley WH, Rutherford TJ, Higgins RV, Secord AA, Fleming G. Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 03; 144(3):459-467. PMID: 28089376.
      Citations: 6     Fields:    Translation:Humans
    12. Thomas ED, Nugent EK, MacAllister MC, Moxley KM, Landrum L, L Walker J, McMeekin DS, Mannel RS, McGwin G, Moore KN. Effectiveness of cyanoacrylate microbial sealant in the reduction of surgical site infection in gynecologic oncology procedures: A phase III single institution prospective randomized trial. Gynecol Oncol. 2017 Jan; 144(1):193-199. PMID: 27836205.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    13. Atri M, Zhang Z, Dehdashti F, Lee SI, Ali S, Marques H, Koh WJ, Moore K, Landrum L, Kim JW, DiSilvestro P, Eisenhauer E, Schnell F, Gold M. Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial. Gynecol Oncol. 2016 Sep; 142(3):413-9. PMID: 27178725.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    14. McMeekin DS, Tritchler DL, Cohn DE, Mutch DG, Lankes HA, Geller MA, Powell MA, Backes FJ, Landrum LM, Zaino R, Broaddus RD, Ramirez N, Gao F, Ali S, Darcy KM, Pearl ML, DiSilvestro PA, Lele SB, Goodfellow PJ. Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study. J Clin Oncol. 2016 09 01; 34(25):3062-8. PMID: 27325856.
      Citations: 28     Fields:    Translation:HumansCells
    15. Gunderson CC, Parsons B, Penaroza S, Peyton MD, Landrum LM. Intravenous leiomyomatosis disguised as a large deep vein thrombosis. J Radiol Case Rep. 2016 May; 10(5):29-35. PMID: 27761178.
      Citations: 3     Fields:    Translation:Humans
    16. Casanegra AI, Landrum LM, Tafur AJ. Retrievable Inferior Vena Cava Filters in Patients with Cancer: Complications and Retrieval Success Rate. Int J Vasc Med. 2016; 2016:6413541. PMID: 26904290.
    17. Tewari KS, Sill MW, Monk BJ, Penson RT, Long HJ, Poveda A, Landrum LM, Leitao MM, Brown J, Reid TJ, Michael HE, Moore DH. Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study. Clin Cancer Res. 2015 Dec 15; 21(24):5480-7. PMID: 26672085.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    18. Landrum LM, Brady WE, Armstrong DK, Moore KN, DiSilvestro PA, O'Malley DM, Tenney ME, Rose PG, Fracasso PM. A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2016 Feb; 140(2):204-9. PMID: 26616225.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    19. Goodfellow PJ, Billingsley CC, Lankes HA, Ali S, Cohn DE, Broaddus RJ, Ramirez N, Pritchard CC, Hampel H, Chassen AS, Simmons LV, Schmidt AP, Gao F, Brinton LA, Backes F, Landrum LM, Geller MA, DiSilvestro PA, Pearl ML, Lele SB, Powell MA, Zaino RJ, Mutch D. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. J Clin Oncol. 2015 Dec 20; 33(36):4301-8. PMID: 26552419.
      Citations: 41     Fields:    Translation:HumansCellsPHPublic Health
    20. Brooks SE, Carter RL, Plaxe SC, Basen-Engquist KM, Rodriguez M, Kauderer J, Walker JL, Myers TK, Drake JG, Havrilesky LJ, Van Le L, Landrum LM, Brown CL. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study. Gynecol Oncol. 2015 Jul; 138(1):101-8. PMID: 25937529.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    21. Landrum LM, Blank S, Chen LM, Duska L, Bae-Jump V, Lee PS, Levine L, McCourt C, Moore KN, Urban RR. Comprehensive care in gynecologic oncology: The importance of palliative care. Gynecol Oncol. 2015 May; 137(2):193-202. PMID: 25749723.
      Citations: 4     Fields:    Translation:Humans
    22. Penson RT, Huang HQ, Wenzel LB, Monk BJ, Stockman S, Long HJ, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Method M, Michael H, Tewari KS. Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). Lancet Oncol. 2015 Mar; 16(3):301-11. PMID: 25638326.
      Citations: 38     Fields:    Translation:HumansCTClinical Trials
    23. Atri M, Zhang Z, Marques H, Gorelick J, Harisinghani M, Sohaib A, Koh DM, Raman S, Gee M, Choi H, Landrum L, Mannel R, Chuang L, Yu JQ, McCourt CK, Gold M. Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN 6671/GOG 0233. Eur J Radiol Open. 2015; 2:11-18. PMID: 25774381.
    24. Moore RG, Hawkins DM, Miller MC, Landrum LM, Gajewski W, Ball JJ, Allard WJ, Skates SJ. Combining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian cancer. Gynecol Oncol. 2014 Dec; 135(3):547-51. PMID: 25449569.
      Citations: 4     Fields:    Translation:Humans
    25. Miller DS, Blessing JA, Ramondetta LM, Pham HQ, Tewari KS, Landrum LM, Brown J, Mannel RS. Pemetrexed and cisplatin for the treatment of advanced, persistent, or recurrent carcinoma of the cervix: a limited access phase II trial of the gynecologic oncology group. J Clin Oncol. 2014 Sep 01; 32(25):2744-9. PMID: 25071133.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    26. Tewari KS, Sill MW, Long HJ, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, Monk BJ. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014 Feb 20; 370(8):734-43. PMID: 24552320.
      Citations: 333     Fields:    Translation:HumansCTClinical Trials
    27. Martin LP, Sill M, Shahin MS, Powell M, DiSilvestro P, Landrum LM, Gaillard SL, Goodheart MJ, Hoffman J, Schilder RJ. A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2014 Mar; 132(3):526-30. PMID: 24361733.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    28. Landrum LM, Nugent EK, Zuna RE, Syzek E, Mannel RS, Moore KN, Walker JL, McMeekin DS. Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors. Gynecol Oncol. 2014 Jan; 132(1):50-4. PMID: 24219982.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    29. Landrum LM, Java J, Mathews CA, Lanneau GS, Copeland LJ, Armstrong DK, Walker JL. Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Jul; 130(1):12-8. PMID: 23578540.
      Citations: 39     Fields:    Translation:Humans
    30. Simpkins F, Papadia A, Kunos C, Michener C, Frasure H, AbuShahin F, Mariani A, Bakkum-Gamez JN, Landrum L, Moore K, Thomas SG, Windhorn A, Rose PG. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion. Int J Gynecol Cancer. 2013 Jan; 23(1):98-104. PMID: 23221731.
      Citations: 11     Fields:    Translation:Humans
    31. Alberts DS, Blessing JA, Landrum LM, Warshal DP, Martin LP, Rose SL, Bonebrake AJ, Ramondetta LM. Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study. Gynecol Oncol. 2012 Dec; 127(3):451-5. PMID: 22986144.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    32. Mathews CA, Stoner JA, Wentzensen N, Moxley KM, Tenney ME, Tuller ER, Myers T, Landrum LM, Lanneau G, Zuna RE, Gold MA, Wang SS, Walker JL. Tubal ligation frequency in Oklahoma women with cervical cancer. Gynecol Oncol. 2012 Nov; 127(2):278-82. PMID: 22858904.
      Citations: 3     Fields:    Translation:Humans
    33. Yang HP, Zuna RE, Schiffman M, Walker JL, Sherman ME, Landrum LM, Moxley K, Gold MA, Dunn ST, Allen RA, Zhang R, Long R, Wang SS, Wentzensen N. Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3. PLoS One. 2012; 7(1):e29051. PMID: 22253702.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    34. Nugent EK, Bishop EA, Mathews CA, Moxley KM, Tenney M, Mannel RS, Walker JL, Moore KN, Landrum LM, McMeekin DS. Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma? Gynecol Oncol. 2012 Apr; 125(1):94-8. PMID: 22155415.
      Citations: 13     Fields:    Translation:Humans
    35. Moore RG, Miller MC, Disilvestro P, Landrum LM, Gajewski W, Ball JJ, Skates SJ. Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass. Obstet Gynecol. 2011 Aug; 118(2 Pt 1):280-288. PMID: 21775843.
      Citations: 63     Fields:    Translation:HumansCTClinical Trials
    36. Landrum LM, Hyde J, Mannel RS, McMeekin DS, Moore KN, Walker JL. Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer. Gynecol Oncol. 2011 Sep; 122(3):527-31. PMID: 21664657.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    37. Moore KN, Frank SG, Alward EK, Landrum LM, Myers TK, Walker JL, Gold MA, McMeekin DS, Vesely SK, Mannel RS. Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population? Cancer. 2009 Apr 01; 115(7):1472-80. PMID: 19235786.
      Citations: 1     Fields:    Translation:Humans
    38. Landrum LM, Moore KN, Myers TK, Lanneau GS, McMeekin DS, Walker JL, Gold MA. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Gynecol Oncol. 2009 Feb; 112(2):337-41. PMID: 19041126.
      Citations: 6     Fields:    Translation:Humans
    39. Moore KN, Reid MS, Fong DN, Myers TK, Landrum LM, Moxley KM, Walker JL, McMeekin DS, Mannel RS. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply? Gynecol Oncol. 2008 Aug; 110(2):133-9. PMID: 18495221.
      Citations: 14     Fields:    Translation:Humans
    40. Landrum LM, Rutledge TL, Osunkoya AO, Mannel R. Uterine leiomyoma with associated pseudo-Meigs syndrome mimicking ovarian carcinoma. J Okla State Med Assoc. 2008 Feb; 101(2):38-9. PMID: 18361033.
      Citations: 1     Fields:    Translation:Humans
    41. Landrum LM, Skaggs V, Gould N, Walker JL, McMeekin DS. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation. Gynecol Oncol. 2008 Mar; 108(3):584-90. PMID: 18155755.
      Citations: 7     Fields:    Translation:Humans
    42. Landrum LM, Gold MA, Moore KN, Myers TK, McMeekin DS, Walker JL. Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates. Gynecol Oncol. 2008 Feb; 108(2):342-7. PMID: 17988721.
      Citations: 5     Fields:    Translation:Humans
    43. Landrum LM, Lanneau GS, Skaggs VJ, Gould N, Walker JL, McMeekin DS, Gold MA. Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era. Gynecol Oncol. 2007 Sep; 106(3):521-5. PMID: 17540438.
      Citations: 3     Fields:    Translation:Humans
    44. Landrum LM, Hawkins A, Goodman JR. Pneumococcal meningitis during pregnancy: a case report and review of literature. Infect Dis Obstet Gynecol. 2009; 2009:63624. PMID: 17485820.
      Citations: 2     Fields:    Translation:HumansCells
    45. Drakopoulou L, Papatriantafyllopoulou C, Terzis A, Perlepes SP, Manessi-Zoupa E, Papaefstathiou GS. Synthesis, X-ray structure, and characterization of a complex containing the hexakis(urea)cobalt(II) cation and lattice urea molecules. Bioinorg Chem Appl. 2007; 51567. PMID: 18288263.
    46. Landrum LM, Jones SL, Blair RW. The expression of Fos-labeled spinal neurons in response to colorectal distension is enhanced after chronic spinal cord transection in the rat. Neuroscience. 2002; 110(3):569-78. PMID: 11906794.
      Citations: 9     Fields:    Translation:AnimalsCells
    47. Landrum LM, Thompson GM, Blair RW. Does postsynaptic alpha 1-adrenergic receptor supersensitivity contribute to autonomic dysreflexia? Am J Physiol. 1998 04; 274(4):H1090-8. PMID: 9575911.
      Citations: 3     Fields:    Translation:AnimalsCells
    Landrum's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (233)
    Co-Authors (13)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors